CAnswer BioSolutions
Snodland
About CAnswer BioSolutions
CAnswer BioSolutions is creating breakthrough cancer diagnostic tools that integrate novel biopsy technology with AI-assisted analysis to revolutionize cancer detection and diagnosis.
Company Facts
- Operating status: Active
- IPO status: Private
- Total funding: $20.0K
- Last round: Grant (Dec 2025)
- Website: canswer-biosolutions.com
- Phone: [email protected]
Industries & Categories
Business Development, Business Intelligence, Software
Social Profiles
Canonical: https://fsome.com/organization/canswer-biosolutions-175799 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.